LORIA, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.642
EU - Europa 6.791
AS - Asia 2.306
SA - Sud America 22
AF - Africa 13
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 24.794
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.619
GB - Regno Unito 2.592
IT - Italia 1.042
SE - Svezia 936
CN - Cina 866
DE - Germania 787
UA - Ucraina 538
TR - Turchia 453
SG - Singapore 427
HK - Hong Kong 387
FI - Finlandia 301
BG - Bulgaria 204
FR - Francia 176
RU - Federazione Russa 49
IN - India 47
BE - Belgio 29
NL - Olanda 28
MY - Malesia 21
CA - Canada 18
CZ - Repubblica Ceca 16
ES - Italia 16
JP - Giappone 16
LT - Lituania 15
IE - Irlanda 14
IR - Iran 14
ID - Indonesia 13
BD - Bangladesh 11
KR - Corea 11
RO - Romania 10
TW - Taiwan 10
AU - Australia 8
CL - Cile 8
CH - Svizzera 7
EU - Europa 7
AT - Austria 6
SI - Slovenia 6
BR - Brasile 5
ET - Etiopia 5
IQ - Iraq 5
MX - Messico 5
AR - Argentina 4
NZ - Nuova Zelanda 4
PH - Filippine 4
UG - Uganda 4
VN - Vietnam 4
CY - Cipro 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
EC - Ecuador 2
EG - Egitto 2
HR - Croazia 2
KW - Kuwait 2
PK - Pakistan 2
PL - Polonia 2
RS - Serbia 2
TH - Thailandia 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
JO - Giordania 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 24.794
Salva come PNG Salva come JPEG
Città #
Fairfield 2.189
Southend 2.017
Woodbridge 1.601
Houston 1.276
Jacksonville 1.218
Chandler 1.197
Ashburn 1.165
Seattle 832
Dearborn 796
Ann Arbor 776
Wilmington 761
Cambridge 720
Nyköping 546
Hong Kong 383
Modena 305
Beijing 303
Izmir 283
Singapore 272
San Diego 235
Princeton 220
Sofia 204
Eugene 201
Des Moines 166
New York 141
Helsinki 104
Grafing 101
Falls Church 86
London 82
Shanghai 73
Bremen 58
Milan 46
Rome 43
Boardman 42
Redwood City 39
Norwalk 35
Kunming 34
San Mateo 33
Fremont 31
Hefei 31
Bologna 26
Brussels 26
Munich 26
Kilburn 23
Guangzhou 20
Nanjing 19
Verona 19
Hounslow 18
Bari 17
Jinan 17
Dongguan 16
Brno 14
Chiswick 14
Nanchang 14
Frankfurt am Main 13
Jakarta 13
Dublin 12
Chicago 11
Parma 11
Indiana 10
Phoenix 10
Auburn Hills 9
Augusta 9
Florence 9
San Francisco 9
Shenyang 9
Taipei 9
Formia 8
Genova 8
Islington 8
Leawood 8
Madrid 8
Mountain View 8
Palermo 8
Saint Petersburg 8
Toronto 8
Washington 8
Amsterdam 7
Baotou 7
Dallas 7
Fuzhou 7
Turin 7
Chengdu 6
Chongqing 6
Dhaka 6
Istanbul 6
Los Angeles 6
Monmouth Junction 6
Monza 6
Napoli 6
Prescot 6
Rio Saliceto 6
Santeramo in Colle 6
Sydney 6
Baghdad 5
Bangalore 5
Hebei 5
Livorno 5
Miami 5
Nishinotoindori 5
Wandsworth 5
Totale 19.270
Salva come PNG Salva come JPEG
Nome #
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 302
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 264
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 225
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 219
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 218
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 208
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 206
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 206
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 198
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 193
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 193
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 192
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 192
Nonalcoholic fatty liver disease and aging: epidemiology to management 191
Gender, fatty liver and GGT 189
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 183
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 179
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 179
Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD) 178
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 177
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 176
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 174
Risk factors for hospital readmission of elderly patients 173
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 173
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 171
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 171
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 170
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 168
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 168
Review article: diabetes, genetics and ethnicity 166
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 164
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 160
Endocrine and liver interaction: the role of endocrine pathways in NASH 159
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 158
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 158
The hepatitis C virus-associated dysmetabolic syndrome. 158
Advances in the comprehension of the pathophysiology of bile secretion 157
Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis 157
Cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size 155
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 155
Effects of acute changes of bile acid pool composition on biliary lipid secretion 154
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 154
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. 154
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 154
From NAFLD in clinical practice to answers from guidelines. 153
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 151
Statins and HCV: a complex issue 149
Chicken or egg turned into head or belly 148
Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of nucleoside reverse transcriptase inhibitors. 148
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 147
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 146
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 145
NAFLD and cardiovascular risk: direct evidence for the tale of two ages. 145
Review article: hepatic steatosis and insulin resistance 145
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 144
Progetto MICOL - Multicentrica Italiana Colelitiasi 143
Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease -Atherosclerosis As a Major Player in the Natural Course of NAFLD. 142
Growth hormone plasma levels in nonalcoholic fatty liver disease 141
Apolipoprotein synthesis in nonalcoholic steatohepatitis 141
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 141
Fisiologia della secrezione biliare. 140
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 140
Of liver, whisky and plants: A requiem for colchicine in alcoholic cirrhosis? 140
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. 140
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 139
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 139
The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption. 138
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 137
Nonalcoholic fatty liver disease activity score and Brunt's pathologic criteria for the diagnosis of nonalcoholic steatohepatitis: what do they mean and do they agree? 137
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 137
Relationship of serum fetuin-a levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography. 137
Nonalcoholic fatty liver disease induced by leuprorelin acetate 136
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 135
Liver and diabetes. A vicious circle 135
The prediction of coronary heart disease mortality as a function of major risk factors in over 30.000 men in the italian RIFLE Pooling Project. A comparison with the MRFIT primary screenees 134
Metabolic alterations and chronic hepatitis C: treatment strategies. 134
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 133
Anatomia e fisiologia delle vie biliari 133
Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid 132
Effect of ursocholic acid on bile lipid secretion and composition 132
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 132
Clinical physiology of NAFLD: A critical overview of pathogenesis and treatment 131
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 130
Influence of age and sex on serum concentrations of total dimeric activin A 130
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 130
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 130
Dysmetabolic changes associated with HCV: a distinct syndrome? 130
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 129
Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies? 129
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 129
Bile acid structure and regulation of biliary protein secretion and composition in man 128
Presentation of the RIFLE Project : Risk factors and life expectancy. 128
Hepatitis C and diabetes: the inevitable coincidence? 128
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 128
Diet and gallstones in Italy: the cross-sectional MICOL results. 127
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 127
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 127
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease 126
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. 126
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 126
Totale 15.627
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.374
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.453 0 0 0 358 569 865 941 502 474 172 332 240
2020/20213.733 363 139 324 320 391 294 369 545 133 452 257 146
2021/20223.583 51 502 394 313 87 156 261 204 392 213 607 403
2022/20233.279 363 354 205 326 401 583 72 310 385 29 142 109
2023/20242.003 84 119 114 136 457 221 216 286 56 42 75 197
2024/2025526 263 87 129 47 0 0 0 0 0 0 0 0
Totale 24.943